These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2698471)

  • 41. The amino acid sequence of a ribosome-inactivating protein from Saponaria officinalis seeds.
    Maras B; Ippoliti R; De Luca E; Lendaro E; Bellelli A; Barra D; Bossa F; Brunori M
    Biochem Int; 1990 Aug; 21(5):831-8. PubMed ID: 2256945
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetically engineered monoclonal antibodies for direct anti-neoplastic treatment and cancer cell specific delivery of chemotherapeutic agents.
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    Curr Pharm Des; 2000 Feb; 6(3):261-76. PubMed ID: 10637379
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Targeted therapy of cancer using diphtheria toxin-derived immunotoxins.
    Potala S; Sahoo SK; Verma RS
    Drug Discov Today; 2008 Sep; 13(17-18):807-15. PubMed ID: 18678276
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatotoxicity of immunotoxins made with saporin, a ribosome-inactivating protein from Saponaria officinalis.
    Stirpe F; Derenzini M; Barbieri L; Farabegoli F; Brown AN; Knowles PP; Thorpe PE
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1987; 53(5):259-71. PubMed ID: 2889289
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunoconjugates made of an anti-EGF receptor monoclonal antibody and type 1 ribosome-inactivating proteins from Saponaria ocymoides or Vaccaria pyramidata.
    Di Massimo AM; Di Loreto M; Pacilli A; Raucci G; D'Alatri L; Mele A; Bolognesi A; Polito L; Stirpe F; De Santis R
    Br J Cancer; 1997; 75(6):822-8. PubMed ID: 9062402
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Novel genetic immunotoxins and intracellular antibodies for cancer therapy.
    Chen SY; Marasco WA
    Semin Oncol; 1996 Feb; 23(1):148-53. PubMed ID: 8607024
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genetic engineering of immunotoxins.
    Chandler JC; Frankel AE; Tagge EP
    Semin Pediatr Surg; 1996 Aug; 5(3):206-11. PubMed ID: 8858768
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunotoxins and cytokine toxin fusion proteins.
    Strom TB; Anderson PL; Rubin-Kelley VE; Williams DP; Kiyokawa T; Murphy JR
    Ann N Y Acad Sci; 1991 Dec; 636():233-50. PubMed ID: 1793213
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A novel method to purify immunotoxins from free antibodies using modified recombinant toxins.
    Dhanabal M; Fryxell DK; Ramakrishnan S
    J Immunol Methods; 1995 Jun; 182(2):165-75. PubMed ID: 7790724
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Human toxin-based recombinant immunotoxins/chimeric proteins as a drug delivery system for targeted treatment of human diseases.
    Lorberboum-Galski H
    Expert Opin Drug Deliv; 2011 May; 8(5):605-21. PubMed ID: 21453191
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Generation of recombinant immunotoxins for specific targeting of tumor-related peptides presented by MHC molecules.
    Cohen CJ; Denkberg G; Segal D; Reiter Y
    Methods Mol Biol; 2003; 207():269-82. PubMed ID: 12412480
    [No Abstract]   [Full Text] [Related]  

  • 52. The unusual stability of saporin, a candidate for the synthesis of immunotoxins.
    Santanché S; Bellelli A; Brunori M
    Biochem Biophys Res Commun; 1997 May; 234(1):129-32. PubMed ID: 9168975
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunotoxins for treatment of leukemia and lymphoma.
    Uckun FM; Reaman GH
    Leuk Lymphoma; 1995 Jul; 18(3-4):195-201. PubMed ID: 8535182
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A chimeric saporin-transferrin conjugate compared to ricin toxin: role of the carrier in intracellular transport and toxicity.
    Ippoliti R; Lendaro E; D'Agostino I; Fiani ML; Guidarini D; Vestri S; Benedetti PA; Brunori M
    FASEB J; 1995 Sep; 9(12):1220-5. PubMed ID: 7672515
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recent advances in the uses and applications of ribosome-inactivating proteins from plants.
    Girbés T; Ferreras JM; Iglesias R; Citores L; De Torre C; Carbajales ML; Jiménez P; De Benito FM; Muñoz R
    Cell Mol Biol (Noisy-le-grand); 1996 Jun; 42(4):461-71. PubMed ID: 8828901
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Saporin, a ribosome-inactivating protein used to prepare immunotoxins, induces cell death via apoptosis.
    Bergamaschi G; Perfetti V; Tonon L; Novella A; Lucotti C; Danova M; Glennie MJ; Merlini G; Cazzola M
    Br J Haematol; 1996 Jun; 93(4):789-94. PubMed ID: 8703804
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cancer-homing toxins.
    Ng HC; Khoo HE
    Curr Pharm Des; 2002; 8(22):1973-85. PubMed ID: 12171523
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Plant-Derived Type I Ribosome Inactivating Protein-Based Targeted Toxins: A Review of the Clinical Experience.
    Flavell DJ; Flavell SU
    Toxins (Basel); 2022 Aug; 14(8):. PubMed ID: 36006226
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression and activity of a recombinant chimeric protein composed of pokeweed antiviral protein and of human interleukin-2.
    Dore JM; Gras E; Wijdenes J
    FEBS Lett; 1997 Jan; 402(1):50-2. PubMed ID: 9013857
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High-speed countercurrent chromatographic recovery and off-line electrospray ionization mass spectrometry profiling of bisdesmodic saponins from Saponaria officinalis possessing synergistic toxicity enhancing properties on targeted antitumor toxins.
    Thakur M; Jerz G; Tuwalska D; Gilabert-Oriol R; Wybraniec S; Winterhalter P; Fuchs H; Weng A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Apr; 955-956():1-9. PubMed ID: 24631804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.